Evidence-Based Management
2020
This chapter primarily focuses on the evidence-based management of patients suffering from rosacea. We divide the chapter into topical followed by systemic therapies. Topical therapies include metronidazole, azelaic acid, ivermectin, calcineurin inhibitors, clindamycin, and more. Systemic therapies include tetracyclines, azithromycin, isotretinoin, and antihypertensives. Each individual section references recent literature supporting both positive and negative results. This chapter allows the reader to have a better understanding of different treatment regimens with valid (or quality) evidence to support (or not support) the use of each individual medication.
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
90
References
0
Citations
NaN
KQI